NL-OMON25723招募中不适用

SEVRA-TRIAL Safety and efficacy of vaccination with T cell-dependent and T cell-independent primary and recall antigens in patients with rheumatoid arthritis treated with anti TNF-á antibodies (adalimumab) and anti B cell therapy (Rituximab).

Philip Remans, MD,PhD, Division of Clinical Immunology and Rheumatology, Hans Schipper, MD, PhD, Department of Internal Medicin, Theo Out, PhD, laboratory of Medical Immunology, René Lutter, PhD, Department of Experimental immunology, Ruth klaasen, MD, Division of Clinical Immunology and Rheumatology, Danielle Gerlag, MD, Division of Clinical Immunology and Rheumatology, Paul P. Tak, MD, PhD, Professor of Medicine.0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年2月28日

研究概览

简要总结

/A

研究设计

研究类型: Interventional

入排标准

入选标准

•1. Able and willing to give written informed consent;
•2. A diagnosed according to the revised 1987 criteria of the American College of Rheumatology (ACR) for at least 3 months;

排除标准

•1. A positive PPD skin test (> 4 mm induration);
•2. Pregnancy;

研究者

发起方

Philip Remans, MD,PhD, Division of Clinical Immunology and Rheumatology, Hans Schipper, MD, PhD, Department of Internal Medicin, Theo Out, PhD, laboratory of Medical Immunology, René Lutter, PhD, Department of Experimental immunology, Ruth klaasen, MD, Division of Clinical Immunology and Rheumatology, Danielle Gerlag, MD, Division of Clinical Immunology and Rheumatology, Paul P. Tak, MD, PhD, Professor of Medicine.

相似试验

已完成

3 期

Rotavirus Efficacy and Safety Trial (REST)(V260-006)Rotavirus Infections

NCT00090233Merck Sharp & Dohme LLC69,274

已完成

2 期

Sanofi H1N1 + TIV - Adults and ElderlyInfluenza

NCT00943878National Institute of Allergy and Infectious Diseases (NIAID)805

已完成

2 期

Sanofi Pasteur, TIV + H1N1, Pediatric PopulationInfluenza

NCT00943202National Institute of Allergy and Infectious Diseases (NIAID)531

Unknown

4 期

The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineRotavirus

NCT02153866Sichuan Center for Disease Control and Prevention2,800

已完成

1 期

ACAM 3000 MVA at Harvard Medical SchoolSmallpox

NCT00133575National Institute of Allergy and Infectious Diseases (NIAID)72